2nd Annual Cancer Immunotherapy Summit

This Summit is focused on Cancer Immunotherapy, the most promising new cancer treatment approach since the development of the first chemotherapies. This summit brings together leading industry professionals in order to expand the scientific horizons of Cancer Immunotherapy, and discuss the latest advances and improvements in research and development.

We will discuss key findings, including critical insights, as well as recommendations for accelerating development in the field.

Key Practical Learning Points of the Summit:

  • Advanced methods, technological developments and strategies in Cancer Immunotherapy
  • The success of antibodies in therapeutics and engineering
  • The true potential of the next generation immune checkpoint pathways
  • Revolutionary cancer treatment with personalised cancer vaccines
  • Reinforcing anti-tumour immunity
  • Biomarkers’ responses
  • Managing unique immune-mediated adverse reactions and toxicity effects
  • Progressive genetic engineering techniques
  • Preclinical and clinical progress in Cancer Immunotherapy
  • CAR T-Cell Therapy: A game changer in cancer treatment
  • Regulatory aspects of the EU and the rest of the world

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Scientists, Investigators and Managers specialising in:

  • Oncology
  • Clinical Diagnostics
  • Drug Discovery
  • Drug Delivery
  • Antibody Engineering
  • Antibody Discovery
  • Cancer Immunotherapy
  • Immuno-Oncology
  • Hematology
  • Translational Medicine Genetics and Genomics
  • Bioinformatics
  • Cancer Genomics
  • Infection and Immunity
  • Cell Therapy Research
  • Cell & Gene Therapy
  • Preclinical Development
  • Tumour Immunology
  • Pathology
  • Vaccines Development
Speakers
Sponsors
Media partners
Partners

Previous Year Attendees

  • National Center for Tumor Diseases (NCT) Heidelberg, Germany

  • Hamamatsu Tissue Imaging and Analysis Center, BIOQUANT, Germany
    Scientific Director

  • Genentech/Roche, Switzerland
    Senior Medical Director, Cancer Immunotherapy

  • QuintilesIMS, UK
    Senior Director, Therapeutic Science & Strategy

  • Shire, Austria
    Director R&D, Antibody Technology

  • Roche Innovation Center Zurich, Switzerland
    Pharmacology Research Area

  • Silenseed LTD, Israel
    CEO

  • University of Southampton, UK
    Associate Professor in Oncology, Cancer Sciences Unit

  • GlaxoSmithKline, UK
    Head of Discovery & New Technologies, Oncology Cell Therapy Unit, Oncology R&D

  • Novartis Pharma AG, Switzerland
    Global Clinical Leader, Oncology Clinical Development

  • AstraZeneca, UK
    Medical Director IO-Gmed

  • AMGEN GmbH, Germany
    Medical Development Director - TA Bone/Inflammation/Neuroscience

  • GE Healthcare, UK
    Product Leader, Cell Therapy

  • NanoTemper Technologies GmbH Munich, Germany
    Senior Application Scientist & Sales

  • Paul-Ehrlich-Institut Langen, Germany
    Head of Tissue Engineering & Somatic Cell Therapeutics

  • Glythera Ltd, UK
    Senior Development Scientist

  • Merck Serono S.p.A., Italy
    Biotech Scientific Manager

  • Agensys, an affiliate of Astellas Pharma, Inc., USA
    Senior Director Pharmacology

  • eTheRNA immunotherapies NV, Belgium
    Chief Scientific Officer

  • Lonza Cologne GmbH, Germany
    Sales Specialist

  • IPSEN Innovation SAS, France
    Senior Regulatory Product Manager

  • Novartis Pharma GmbH, Germany
    Medical Advisor

  • Ablynx NV, Belgium
    Senior Research Fellow

  • Charles River, UK
    Senior Director Scientific Alliances

  • Orion Clinical Services Ltd., UK
    Associate Medical Director

  • NeoGenomics Laboratories, USA
    Vice President Pharma Services, International Sales & Business Development

  • BioNTech Small Molecules GmbH, Germany
    Head of Small Molecules

  • Personalis, Inc., USA
    Executive Account Manager D/A/CH

  • Illumina GmbH, Germany
    District Marketing Manager, Central Europe

  • Lonza AG, Switzerland
    R&T Pharma & Biotech

  • Advanced Cell Diagnostics SRL, Italy
    Senior Director Europe, ACD SRL

  • Symphogen Inc., USA
    V.P of Project Management & Clinical Operation

  • Illumina Cambridge Ltd, UK
    Director, Business Development

  • Myriad RBM, Inc., USA
    Director, Business Development

  • HISTALIM, SARL, France
    Project Manager

  • Heraeus Deutschland GmbH & Co. KG, Germany
    Global Head Projectmanagement Pharmaceutical Ingredients

  • Crown Bioscience Inc., USA
    Director of Business Development

  • Invectys SA, France
    CEO

  • Glycotope GmbH, Germany
    CMO

  • Bayer Pharma AG, Germany
    Head Clinical Pharmacology Oncology

  • Polypure AS, Norway
    COO

  • ProteinSimple, USA
    Global Pharma and Partners Manager - Simple Plex